source
- Webinar Explores Manufacturing Risks and Partner Strategies for the Next Five YearsThe webinar titled "Manufacturing in Turbulent Times" is scheduled for September 17, 2026 and is designed to help biopharma sponsors understand the manufacturing challenges that lie ahead. It note…
- Biotech hedge fund launches North Immunology to develop long-acting antibody for atopic dermatitisSTAT+ hedge fund is creating a new immunology company called North Immunology with the goal of delivering a better, long-acting antibody therapy for atopic dermatitis. The concept originated two y…